| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 166.38× | 166.38× | 185.31× | 196.81× | 238.63× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.07× | 1.02× | 1.20× | 1.44× | 1.38× | ||
| 0.37× | 0.37× | 0.35× | 0.35× | 0.29× | ||
| −2.73× | −2.73× | 0.24× | 2.84× | 3.53× | ||
| −0.77× | −0.77× | 0.12× | 0.89× | −0.41× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 238.63 | 196.81 | 185.31 | 166.38 | 166.38 | |
| Working Capital Turnover | 1.38 | 1.44 | 1.20 | 1.02 | 1.07 | |
| Asset Turnover | 0.29 | 0.35 | 0.35 | 0.37 | 0.37 | |
| Cash Conversion (CFO/Net Income) | 3.53 | 2.84 | 0.24 | -2.73 | -2.73 | |
| CFO/EBITDA | -0.41 | 0.89 | 0.12 | -0.77 | -0.77 |